Form D Explorer

Form C-U — 20/20 Biolabs, Inc.

0001665160-23-000097 · filed 2023-01-19 · via StartEngine Capital, LLC

🔍 Find website on Google

Offering

Target: $9,995
Maximum: $4,999,995
Security type: Other
Price per security: —
Deadline: —
Oversubscription: Accepted

Issuer

Name: 20/20 Biolabs, Inc.
CIK: 1139685
Entity: Corporation
Jurisdiction: DE
Address: 15810 GAITHER ROAD, SUITE 235
GAITHERSBURG, MD 20877
Phone: —

Most recent fiscal year financials

Total assets

$10,272,281

Cash

—

Short-term debt

—

Long-term debt

—

Revenues

$9,622,332

COGS

$4,927,374

Taxes paid

—

Net income

$2,071,777

Same issuer's Form D filings

D · 2025-02-26

$3M

View original on SEC EDGAR.